Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05766891
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Group 1 — BEHAVIORALParticipants will receive hypnosedation will be restarted after arriving in the operating room and will continue for the whole time of surgery
- Group 2 — BEHAVIORALParticipants will receive standard general anesthesia and medications to control your pain after arriving in the operating room
- Group 3 — BEHAVIORALParticipants will receive standard general anesthesia and medications during surgery to control your pain.
Study Details
To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.
Key Dates
- Start date
- Oct 12, 2023
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 225 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Group 1Participants will receive hypnosedation before and during surgery as well as local anesthesia and pain/nausea medications during surgery
- Experimental: Group 2Participants will receive hypnosedation before surgery and standard general anesthesia during surgery.
- Experimental: Group 3Participants will receive standard general anesthesia alone. You will not receive hypnosedation.
Primary Outcome Measure
Morphine Equivalent Daily Dose (MEDD) [ Time Frame: through study completion; an average of 1 year. ]
Central Contacts
- Lorenzo Cohen, MD(713) 745-4260
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Lorenzo Cohen, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska